Nabumetone - 0378-3016-05 - (nabumetone)

Alphabetical Index


Drug Information of Nabumetone

Product NDC: 0378-3016
Proprietary Name: Nabumetone
Non Proprietary Name: nabumetone
Active Ingredient(s): 750    mg/1 & nbsp;   nabumetone
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Nabumetone

Product NDC: 0378-3016
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090516
Marketing Category: ANDA
Start Marketing Date: 20120821

Package Information of Nabumetone

Package NDC: 0378-3016-05
Package Description: 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3016-05)

NDC Information of Nabumetone

NDC Code 0378-3016-05
Proprietary Name Nabumetone
Package Description 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-3016-05)
Product NDC 0378-3016
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name nabumetone
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120821
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name NABUMETONE
Strength Number 750
Strength Unit mg/1
Pharmaceutical Classes Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]

Complete Information of Nabumetone


General Information